Retinol Binding Protein, Random, Urine
Thrombopoietin
Pruritus ani
Factor II (Prothrombin) Mutation
T-Cell Antigen Receptor, Gamma (TRG@) Gene Rearrangement Analysis for Abnormal Clonality, Amplified Method, Bone Marrow
Dopamine beta-hydroxylase (DBH) Genetic Variations
Group B Streptococcus (GBS), Molecular Detection, PCR
Hepatitis E Virus (HEV) Antibody, IgM
Adiponectin
Complete Blood Cell Count (CBC)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Interpretation
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...